David Arkowitz

Chief Financial Officer, IDENIX PHARMACEUTICALS INC.

Companies

iBio, Inc.Board member Nov 25, 2024 to now¹
Proteostasis Therapeutics (United States)Board member Mar 8, 2019 to now²
Seres Therapeutics, Inc.Chief financial officer Jun 1, 2021 to Feb 16, 2024³
F-star Therapeutics, Inc.Board member May 5, 2016 to Mar 9, 2023⁴
Seres Therapeutics, Inc.Officer Feb 8, 2022 to Feb 8, 2022⁵
Flexion TherapeuticsChief financial officer May 7, 2018 to May 12, 2021⁶
AMAG PharmaceuticalsChief financial officer Apr 5, 2007 to Jun 1, 2011⁷

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 30, 2025Returned to company 16,571 shares of Proteostasis Therapeutics (United States)¹⁰
Jun 25, 2025Granted 6,000 shares of Proteostasis Therapeutics (United States)¹²
Jun 23, 2025Shares withheld for tax 4,706 shares at $0.26 of Proteostasis Therapeutics (United States)¹²
Jun 23, 2025Exercised options 12,500 shares at $0.61 of Proteostasis Therapeutics (United States)¹²
Jan 10, 2025Bought 18,382 shares at $2.72 of iBio, Inc.⁹
Feb 16, 2024Sold 3,939 shares at $1.08 of Seres Therapeutics, Inc.⁸
Feb 15, 2024Exercised options 10,625 shares of Seres Therapeutics, Inc.⁸
Oct 30, 2023Sold 4,066 shares at $1.35 of Seres Therapeutics, Inc.¹³
Oct 27, 2023Exercised options 13,209 shares of Seres Therapeutics, Inc.¹³
Apr 27, 2023Granted 42,500 shares of Seres Therapeutics, Inc.¹⁴
Mar 8, 2023U 8,386 shares at $7.12 of F-star Therapeutics, Inc.¹¹
Oct 27, 2022Granted 42,500 shares of Seres Therapeutics, Inc.¹⁵
Jul 5, 2022Granted 63,492 shares at $3.15 of Seres Therapeutics, Inc.¹⁶
Jun 15, 2022Exercised options 5,000 shares of Seres Therapeutics, Inc.¹⁵

The numbers on this page point here. Each one links to the record it came from.